Content

Past Issues

Download Magazine

Search

Subscribe

  • This field is for validation purposes and should be left unchanged.

Welcome

Welcome

Error: No layouts found

Yaron Tomer, M.D.

Tomer

Dr. Tomer, a leading endocrinology researcher and clinician, has joined EinsteinMontefiore as professor and university chair of the department of medicine. Dr. Tomer was previously at the Icahn School of Medicine at Mount Sinai, where he served as vice chair for research; division chief of endocrinology, diabetes and bone disease; and the Lillian and Henry M. Stratton Professor of Molecular Medicine. As endocrinology division chief, he expanded the clinical and research operations in endocrinology, including the creation of centers for diabetes, pituitary and adrenal disorders and the medical management of obesity.

Dr. Tomer is the author of more than 170 manuscripts and book chapters and has served on the editorial boards of several journals, including Endocrinology, the Journal of Clinical Endocrinology & Metabolism, Autoimmune Reviews and Thyroid. He is a member of the American Society for Clinical Investigation, and a fellow of the American College of Physicians as well as the American College of Endocrinology. He is the recipient of several national awards, including the American Thyroid Association’s highest honor, the Van Meter Award.

 

Balazs Halmos, M.D., M.S.

Halmos

Dr. Halmos has joined Einstein-Montefiore as director of the thoracic oncology program and of clinical cancer genetics and a professor of clinical medicine. Dr. Halmos completed his clinical and laboratory research training in hematology/oncology at Beth Israel Deaconess Medical Center/Harvard Medical School. He was director of thoracic medical oncology at Columbia University Medical Center before coming to Einstein-Montefiore.

Dr. Halmos is an authority on managing lung and gastroesophageal cancers and thymomas. His clinical and laboratory research efforts focus on developing agents for treating thoracic malignancies and the genomic basis for drug resistance. He’ll inaugurate a program for obtaining genomic information from tumor specimens and tying this information to patient care.

The Issue at a Glance

More From Einstein

Class of 2024 Celebrates Match Day
Einstein Community Enjoys Pi Day
Graduate Students Win Marmur Award
Empowering Einstein Women in Science
Einstein Secures $192M in NIH Grants
Training the Next Cancer Researchers
Bringing a Novel Drug to Market
A Promise to Rwandan Genocide Survivors